On the other hand, CD63, a marker for azurophilic degranulation (28), was markedly upregulated in LDNs of patients with mild and severe COVID-19 (Figure 3B) (an effect not evident in whole blood, Supplemental Figure 2D). The gene discussed is CD63; the disease is COVID-19.